Results for the very first human embryonic stem cell treatment were announced today in the online first section of The Lancet journal. The first aim of the study was to determine if the stem cell transplant was a safe treatment for age-related dry macular degeneration (dry AMD), the main cause of blindness in persons over 60. But, in addition...